B
DBD icon

Bayban’s Diebold Nixdorf DBD Stock Holding History

Bayban’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$604 – 607
2026
Q1 		$604 Buy
+8
New +$589 ﹤0.01% 647

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $368M AUM 57.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bayban's DBD Position: Q2 2026 in Review

Bayban sold out of Diebold Nixdorf (DBD) in Q2 2026, closing a stake of 8 shares — an estimated $604 sold.

Bayban first reported a position in DBD in Q1 2026 and held it in 1 quarter. The position peaked at $604 in Q1 2026. 203 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Bayban reported no remaining Diebold Nixdorf position as of Q2 2026 after selling out during the quarter.
  • Bayban sold 8 Diebold Nixdorf shares in Q2 2026, an estimated $604.
  • Bayban first reported a position in Diebold Nixdorf in Q1 2026 and held it in 1 quarter.
  • Bayban's Diebold Nixdorf position peaked at $604 in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.